3,4-dihydroxyphenylacetic acid has been researched along with bromocriptine in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (42.42) | 18.7374 |
| 1990's | 12 (36.36) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Dolphin, AC; Jenner, P; Marsden, CD; Sawaya, MC; Testa, B | 1 |
| Saiani, L; Spano, PF; Tonon, G; Trabucchi, M | 1 |
| Battaini, F; Hofmann, M; Spano, P; Tonon, G; Trabucchi, M | 1 |
| Di Chiara, G; Gessa, GL; Porceddu, ML; Vargiu, L | 2 |
| di Chiara, G; Gessa, GL; Porceddu, ML; Stefanini, E; Vargiu, L | 1 |
| Lookingland, KJ; Moore, KE; Toney, TW | 1 |
| Cox, RF; Jackson, DM; Larsson, LG; Martin, LP; Ross, SB; Waszczak, BL | 1 |
| Bédard, PJ; Di Paolo, T; Rouillard, C | 1 |
| Bédard, P; Boucher, R; Daigle, M; Di Paolo, T | 1 |
| Bédard, P; Di Paolo, T; Falardeau, P; Rouillard, C | 1 |
| Baden, DR; Kenny, AM; Murrin, LC; Pfeiffer, RF; Schneider, MB | 1 |
| Cherchi, A; Gessa, GL; Mercuro, G; Rivano, AC; Rossetti, Z; Ruscazio, M; Stefanini, E; Tocco, L | 1 |
| Cherchi, A; Gessa, GL; Mercuro, G; Rivano, CA; Rossetti, ZL; Tocco, L | 1 |
| Globus, M; Melamed, E | 1 |
| Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB | 1 |
| de Vries, JB; Feenstra, MG; Goedemoed, JH; Horn, AS; Rollema, H; Sumners, C | 1 |
| Brannan, T; Di Rocco, A; Martínez-Tica, J; Yahr, MD | 1 |
| Bengtsson, A; Georgiev, J; Jackson, DM; Larsson, LG; Magnusson, O; Mohell, N; Ross, SB | 1 |
| Bymaster, FP; Threlkeld, PG; Wong, DT | 1 |
| Pan, JT; Yang, JY | 1 |
| Capelli, M; Flamigni, C; Grossi, G; Paradisi, R; Pasquali, R; Porcu, E; Rocchi, G; Venturoli, S | 1 |
| Bédard, PJ; Boucher, R; Di Paolo, T; Gagnon, C; Gomez-Mancilla, B; Markstein, R | 1 |
| Crambes, O; Pagliari, R; Peyrin, L | 1 |
| Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y | 1 |
| Fujisaki, Y; Inoue, K; Iwasaki, S; Kiriike, N; Kurioka, M; Yamagami, S | 1 |
| Asanuma, M; Ogawa, N; Tanaka, K | 1 |
| MohanKumar, PS; MohanKumar, SM; Quadri, SK; Voogt, JL | 1 |
| Mohanasundari, M; Sabesan, M; Sethupathy, S; Srinivasan, MS | 1 |
| Harkitis, P; Johnson, EO; Konstandi, M; Marselos, M; Ogren, SO; Thermos, K; Tzimas, P | 1 |
| Bácskay, I; Fehér, P; Freeman, ME; Ihm, Z; Kiss, T; Nagy, GM; Oláh, M; Vecsernyés, M | 1 |
| Aquino, NSS; Gusmao, DO; Henriques, PC; Reis, AM; Silva, KSC; Szawka, RE | 1 |
33 other study(ies) available for 3,4-dihydroxyphenylacetic acid and bromocriptine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Brain; Bromocriptine; Dopamine; Female; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Mice; Molecular Conformation; Motor Activity; Norepinephrine; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1977 |
Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Bromocriptine; Caudate Nucleus; Cyclic AMP; Dopamine; Haloperidol; Male; Rats; Receptors, Dopamine; Reserpine; Substantia Nigra | 1979 |
Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Bromocriptine; Corpus Striatum; Ergolines; Male; Metergoline; Nucleus Accumbens; Phenylacetates; Prolactin; Rats; Sulpiride | 1979 |
Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Bromocriptine; Dopamine; Drug Interactions; Ergolines; Mice; Motor Activity; Pimozide; Receptors, Dopamine; Stimulation, Chemical | 1977 |
Evidence for selective and long-lasting stimulation of "regulatory" dopamine-receptors by bromocriptine (CB 154).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain Chemistry; Bromocriptine; Dopamine; Homovanillic Acid; Male; Mice; Motor Activity; Receptors, Dopamine; Stimulation, Chemical; Synaptosomes; Time Factors | 1977 |
Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Receptors, Dopamine; Time Factors | 1978 |
Role of testosterone in the regulation of tuberoinfundibular dopaminergic neurons in the male rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Dihydroxyphenylalanine; Dopamine; Injections, Intraventricular; Male; Median Eminence; Neurons; Orchiectomy; Prolactin; Rats; Rats, Inbred Strains; Sex Characteristics; Stress, Physiological; Testosterone | 1991 |
Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Bromocriptine; Dihydroxyphenylalanine; Dopamine; Electrophysiology; Homovanillic Acid; Hydrazines; Male; Mice; Mice, Inbred Strains; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotaxic Techniques | 1990 |
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone | 1990 |
Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Bromocriptine; Catecholamines; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Prolactin; Pyridines | 1986 |
Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Appetite Depressants; Benzazepines; Bromocriptine; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Hydroxydopamines; Locomotion; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 1988 |
Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Bromocriptine; Dopamine; Drug Administration Schedule; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra; Time Factors | 1986 |
[Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Blood Pressure; Bromocriptine; Dihydroergotoxine; Domperidone; Double-Blind Method; Heart Rate; Humans; Hypertension; Male; Norepinephrine; Random Allocation; Receptors, Dopamine | 1987 |
Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Blood Pressure; Bromocriptine; Depression, Chemical; Epinephrine; Female; Heart Rate; Humans; Hypotension; Male; Norepinephrine; Phenylacetates; Time Factors | 1985 |
Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Levodopa; Male; Muridae; Receptors, Dopamine; Synaptic Transmission | 1983 |
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1984 |
A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Behavior, Animal; Bromocriptine; Dopamine; Ergolines; Homovanillic Acid; Models, Neurological; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
Low and high dose bromocriptine have different effects on striatal dopamine release: an in vivo study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley | 1993 |
Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine; Hydroxyindoleacetic Acid; Kinetics; Male; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1995 |
Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Binding, Competitive; Brain Chemistry; Bromocriptine; Cattle; Corpus Striatum; Dopamine; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; In Vitro Techniques; Membranes; Pergolide; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2 | 1993 |
Enhanced tuberoinfundibular dopaminergic neuron activity in thyroidectomized, ovariectomized and estrogen-treated rats with hyperprolactinemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Cysteamine; Dopamine; Estrogens; Female; Hyperprolactinemia; Hypothalamus; Neurons; Ovariectomy; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Thyroidectomy; Thyroxine | 1994 |
Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Brain; Bromocriptine; Catecholamines; Dopamine; Female; Gonadal Steroid Hormones; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Pituitary Hormones; Polycystic Ovary Syndrome; Pregnancy | 1993 |
Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Homovanillic Acid; Indoles; Locomotion; Macaca fascicularis; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Phenanthridines; Psychomotor Performance; Receptors, Dopamine; Receptors, Dopamine D1 | 1993 |
Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agonists; Homovanillic Acid; Injections, Intraperitoneal; Kinetics; Male; Microdialysis; Neostriatum; Nucleus Accumbens; Piribedil; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 1995 |
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles | 1997 |
Bromocriptine enhances feeding behavior without changing dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Bromocriptine; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agonists; Dopamine Antagonists; Eating; Extracellular Space; Female; Homovanillic Acid; Microdialysis; Microinjections; Neostriatum; Rats; Rats, Wistar; Receptors, Dopamine D2; Stimulation, Chemical; Sulpiride | 1997 |
Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2000 |
Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Dopamine; Dopamine Agonists; Estrus; Female; Gene Expression; Hyperprolactinemia; Median Eminence; Neuronal Plasticity; Prolactin; Pseudopregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tyrosine 3-Monooxygenase | 2001 |
Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Ataxia; Bromocriptine; Catalase; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Glutathione; Glutathione Peroxidase; Hand Strength; Hypericum; Lipid Peroxidation; Locomotion; Male; Mice; MPTP Poisoning; Muscle Weakness; Neuroprotective Agents; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Superoxide Dismutase | 2006 |
Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(alpha)pyrene.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Benzo(a)pyrene; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Drug Interactions; Homovanillic Acid; Male; Radioligand Assay; Rats; Rats, Wistar; Sulpiride | 2007 |
Dopamine-regulated adrenocorticotropic hormone secretion in lactating rats: functional plasticity of melanotropes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; alpha-Methyltyrosine; alpha-MSH; Animals; Bromocriptine; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Estradiol; Female; Lactation; Ovariectomy; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2009 |
Reduced dopaminergic tone during lactation is permissive to the hypothalamic stimulus for suckling-induced prolactin release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Suckling; Bromocriptine; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Hypothalamus; Lactation; Median Eminence; Pituitary Gland, Intermediate; Prolactin; Prolactin-Releasing Hormone; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2020 |